Tongcheng Travel 2025Q1 Secures Foothold in the Mass Travel Market Revenue Grows 13.2% Yoy to RMB4.4 Billion

Rising Travel Spending Boosts Core OTA Business Growth AI Empowers High-Quality Development…

Leptage Debuts at TOKEN2049 Dubai: Showcasing Innovations in Web3 Infrastructure

WARSAW, Poland, May 23, 2025 /PRNewswire/ — Leptage, a modern fintech platform…

Compass Mining Partners with Synota's "Impact Mining" Initiative to Transform Bitcoin Hashrate into Community Impact

Initial donation supports a hospital and village in Nigeria, with plans for…

41st WHO Sasakawa Health Prize Awarded to Denmark's Dr. Merete Nordentoft For Work on Suicide Prevention in Young People

TOKYO, May 23, 2025 /PRNewswire/ — The 41st WHO Sasakawa Health Prize was…

NYSE Content Advisory: Pre-Market update + Hinge Health, MNTN pop double digits in trading debuts

NEW YORK, May 23, 2025 /PRNewswire/ — The New York Stock Exchange…

WGC2025 | ENN Leverages "Intelligence + Low Carbon" to Pioneer a New Paradigm for Sustainable Energy Development

LANGFANG, China, May 23, 2025 /PRNewswire/ — From May 19 to 23,…

Enterprises from 39 Countries Join WCIFIT, with Thailand, Hong Kong, and Sichuan in the Spotlight

CHONGQING, China, May 23, 2025 /PRNewswire/ — A news report from iChongqing: Over…

UniXell Biotechnology announces the first patient dosed with UX-DA001, an investigational autologous iPSC based cell therapy for the treatment of Parkinson's disease, in its Phase 1 study

SHANGHAI, May 23, 2025 /PRNewswire/ — Shanghai UniXell Biotechnology Co., Ltd. (UniXell…